Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Current Alzheimer Research|August 12, 2008
An increase in Abeta42 in the prefrontal cortex is associated with a reversal-learning impairment in Alzheimer's disease model Tg2576 APPsw miceJia-Min Zhuo, Annamalai Prakasam, Melissa E Murray, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2010
Differential accumulation of secreted AbetaPP metabolites in ocular fluidsAnnamalai Prakasam, Anusuya Muthuswamy, Zsolt Ablonczy, et al.
Molecular Neurobiology|September 11, 2014
Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer's Disease (AD) and Age-Related Macular Degeneration (AMD)Yuhai Zhao, Surjyadipta Bhattacharjee, Brandon M Jones, et al.
Analytical Biochemistry|November 7, 2025
Sulfur amino acids, metabolic health and beyond: Recent advances, translational implications, and future research considerationsThomas Olsen, Amany Elshorbagy, Jay E Johnson, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 4, 2003
17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary studyLaura D Baker, Kumar Sambamurti, Suzanne Craft, et al.
Current Drug Targets|July 24, 2004
Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factorsKumar Sambamurti, Ann-Charlotte Granholm, Mark S Kindy, et al.
Current Alzheimer Research|December 20, 2014
Amyloid-beta protein clearance and degradation (ABCD) pathways and their role in Alzheimer's diseaseRobert J Baranello, Krishna L Bharani, Vasudevaraju Padmaraju, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2003
Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivoBonnie C Miller, Elizabeth A Eckman, Kumar Sambamurti, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 28, 2006
The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and miceDebomoy K Lahiri, DeMao Chen, Bryan Maloney, et al.
Journal of Alzheimer'S Disease : JAD|November 26, 2002
Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in ratTadanobu Utsuki, Mohammed Shoaib, Harold W Holloway, et al.
Pageof 9